Plancorp LLC Has $929,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Plancorp LLC grew its holdings in Danaher Co. (NYSE:DHR) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,046 shares of the conglomerate’s stock after buying an additional 335 shares during the quarter. Plancorp LLC’s holdings in Danaher were worth $929,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. Howard Capital Management Group LLC increased its stake in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares in the last quarter. Citizens Financial Group Inc. RI boosted its holdings in Danaher by 17.3% in the third quarter. Citizens Financial Group Inc. RI now owns 16,940 shares of the conglomerate’s stock valued at $4,713,000 after acquiring an additional 2,499 shares during the last quarter. LPL Financial LLC boosted its holdings in Danaher by 7.4% in the third quarter. LPL Financial LLC now owns 379,341 shares of the conglomerate’s stock valued at $105,464,000 after acquiring an additional 26,124 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in Danaher by 0.4% in the third quarter. Pacer Advisors Inc. now owns 51,110 shares of the conglomerate’s stock valued at $14,210,000 after acquiring an additional 220 shares during the last quarter. Finally, Lathrop Investment Management Corp boosted its holdings in Danaher by 13.8% in the third quarter. Lathrop Investment Management Corp now owns 25,705 shares of the conglomerate’s stock valued at $7,147,000 after acquiring an additional 3,125 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on DHR shares. Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target on the stock. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Robert W. Baird decreased their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price on the stock in a report on Friday. Finally, Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $278.24.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 10.90% of the company’s stock.

Danaher Stock Up 0.7 %

Shares of Danaher stock opened at $211.63 on Friday. The business’s 50 day simple moving average is $217.46 and its 200 day simple moving average is $238.86. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The firm has a market cap of $151.26 billion, a PE ratio of 40.08, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm posted $2.09 EPS. On average, analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.